Nuvalent Appoints Anna Protopapas as Chair of Board of Directors
/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical stage biopharmaceutical company creating precisely targeted therapies for clinically proven kinase...
Source: prnewswire.com
Nuvalent Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nuvalent Board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nuvalent Board Today - Breaking & Trending Today
Nuvalent Appoints Emily Drabant Conley, PhD, to Board of Directors
/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a biotechnology company creating precisely targeted therapies for clinically proven kinase targets in cancer,...
Source: prnewswire.com
Nuvalent Appoints Emily Drabant Conley, PhD, to Board of Directors
/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a biotechnology company creating precisely targeted therapies for clinically proven kinase targets in cancer,...
Source: prnewswire.com
Nuvalent Closes $135M Series B Financing
Nuvalent, Inc., a Cambridge, Mass.-based biotechnology company creating precisely targeted therapies for clinically proven kinase targets in cancer, closed a $135m Series B financing. The round was led by Bain Capital Life Sciences with participation from sole founding investor, Deerfield Management, and additional new investors Fidelity Management and Research Company LLC, Wellington Management Company, Viking Global Investors, Janus Henderson Investors, Avoro Capital Advisors, Boxer Capital of Tavistock Group, Venrock Healthcare Capital Partners, Fairmount Funds Management LLC, Driehaus C...
Source: finsmes.com